Selected research
Industry Growth & Trends
Global Bifidus Industry Growth and Trends Forecast to 2032
Market perspective
The global Bifidus market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma and Shandong Zhongke Jiayi Bioengineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bifidus market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bifidus market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bifidus market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bifidus.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Bifidus market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bifidus Market by Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Bifidus Segment by Type
Food Grade
Pharmaceutical Grade
Bifidus Segment by Application
Food & Beverages
Medicines
Health Products
Others
Bifidus Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bifidus manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharmaceutical Grade
Applications
- Food & Beverages
- Medicines
- Health Products
- Others
Companies covered
- Chr-Hansen
- DuPont
- Wecare Probiotics
- Probi
- Mitushi Bio Pharma
- Scitop Bio-tech
- Lallemand
- Goerlich Pharma
- Shandong Zhongke Jiayi Bioengineering
- Danone
- Shanghai SPH Sinopharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bifidus Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bifidus Sales Estimates and Forecasts (2021-2032)
- 1.3 Bifidus Market by Type
- 1.3.1 Food Grade
- 1.3.2 Pharmaceutical Grade
- 1.4 Global Bifidus Market Size by Type
- 1.4.1 Global Bifidus Market Size Overview by Type (2021-2032)
- 1.4.2 Global Bifidus Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Bifidus Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Bifidus Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Bifidus Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Bifidus Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Bifidus Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Bifidus Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Bifidus Industry Trends
- 2.2 Bifidus Industry Drivers
- 2.3 Bifidus Industry Opportunities and Challenges
- 2.4 Bifidus Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Bifidus Revenue (2021-2026)
- 3.2 Global Top Players by Bifidus Sales (2021-2026)
- 3.3 Global Top Players by Bifidus Price (2021-2026)
- 3.4 Global Bifidus Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidus Major Company Production Sites & Headquarters
- 3.6 Global Bifidus Company, Product Type & Application
- 3.7 Global Bifidus Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifidus Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifidus Players Market Share by Revenue in 2025
- 3.8.3 2025 Bifidus Tier 1, Tier 2, and Tier 3
4 Bifidus Regional Status and Outlook
- 4.1 Global Bifidus Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Bifidus Historic Market Size by Region
- 4.2.1 Global Bifidus Sales in Volume by Region (2021-2026)
- 4.2.2 Global Bifidus Sales in Value by Region (2021-2026)
- 4.2.3 Global Bifidus Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Bifidus Forecasted Market Size by Region
- 4.3.1 Global Bifidus Sales in Volume by Region (2027-2032)
- 4.3.2 Global Bifidus Sales in Value by Region (2027-2032)
- 4.3.3 Global Bifidus Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bifidus by Application
- 5.1 Bifidus Market by Application
- 5.1.1 Food & Beverages
- 5.1.2 Medicines
- 5.1.3 Health Products
- 5.1.4 Others
- 5.2 Global Bifidus Market Size by Application
- 5.2.1 Global Bifidus Market Size Overview by Application (2021-2032)
- 5.2.2 Global Bifidus Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Bifidus Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Bifidus Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Bifidus Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Bifidus Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Bifidus Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Bifidus Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Chr-Hansen
- 6.1.1 Chr-Hansen Company Information
- 6.1.2 Chr-Hansen Business Overview
- 6.1.3 Chr-Hansen Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Chr-Hansen Bifidus Product Portfolio
- 6.1.5 Chr-Hansen Recent Developments
- 6.2 DuPont
- 6.2.1 DuPont Company Information
- 6.2.2 DuPont Business Overview
- 6.2.3 DuPont Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 DuPont Bifidus Product Portfolio
- 6.2.5 DuPont Recent Developments
- 6.3 Wecare Probiotics
- 6.3.1 Wecare Probiotics Company Information
- 6.3.2 Wecare Probiotics Business Overview
- 6.3.3 Wecare Probiotics Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Wecare Probiotics Bifidus Product Portfolio
- 6.3.5 Wecare Probiotics Recent Developments
- 6.4 Probi
- 6.4.1 Probi Company Information
- 6.4.2 Probi Business Overview
- 6.4.3 Probi Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Probi Bifidus Product Portfolio
- 6.4.5 Probi Recent Developments
- 6.5 Mitushi Bio Pharma
- 6.5.1 Mitushi Bio Pharma Company Information
- 6.5.2 Mitushi Bio Pharma Business Overview
- 6.5.3 Mitushi Bio Pharma Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
- 6.5.5 Mitushi Bio Pharma Recent Developments
- 6.6 Scitop Bio-tech
- 6.6.1 Scitop Bio-tech Company Information
- 6.6.2 Scitop Bio-tech Business Overview
- 6.6.3 Scitop Bio-tech Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Scitop Bio-tech Bifidus Product Portfolio
- 6.6.5 Scitop Bio-tech Recent Developments
- 6.7 Lallemand
- 6.7.1 Lallemand Company Information
- 6.7.2 Lallemand Business Overview
- 6.7.3 Lallemand Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Lallemand Bifidus Product Portfolio
- 6.7.5 Lallemand Recent Developments
- 6.8 Goerlich Pharma
- 6.8.1 Goerlich Pharma Company Information
- 6.8.2 Goerlich Pharma Business Overview
- 6.8.3 Goerlich Pharma Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Goerlich Pharma Bifidus Product Portfolio
- 6.8.5 Goerlich Pharma Recent Developments
- 6.9 Shandong Zhongke Jiayi Bioengineering
- 6.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
- 6.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
- 6.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
- 6.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
- 6.10 Danone
- 6.10.1 Danone Company Information
- 6.10.2 Danone Business Overview
- 6.10.3 Danone Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Danone Bifidus Product Portfolio
- 6.10.5 Danone Recent Developments
- 6.11 Shanghai SPH Sinopharm
- 6.11.1 Shanghai SPH Sinopharm Company Information
- 6.11.2 Shanghai SPH Sinopharm Business Overview
- 6.11.3 Shanghai SPH Sinopharm Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
- 6.11.5 Shanghai SPH Sinopharm Recent Developments
7 North America by Country
- 7.1 North America Bifidus Sales by Country
- 7.1.1 North America Bifidus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Bifidus Sales by Country (2021-2026)
- 7.1.3 North America Bifidus Sales Forecast by Country (2027-2032)
- 7.2 North America Bifidus Market Size by Country
- 7.2.1 North America Bifidus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Bifidus Market Size by Country (2021-2026)
- 7.2.3 North America Bifidus Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Bifidus Sales by Country
- 8.1.1 Europe Bifidus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Bifidus Sales by Country (2021-2026)
- 8.1.3 Europe Bifidus Sales Forecast by Country (2027-2032)
- 8.2 Europe Bifidus Market Size by Country
- 8.2.1 Europe Bifidus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Bifidus Market Size by Country (2021-2026)
- 8.2.3 Europe Bifidus Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Bifidus Sales by Country
- 9.1.1 Asia-Pacific Bifidus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Bifidus Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Bifidus Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Bifidus Market Size by Country
- 9.2.1 Asia-Pacific Bifidus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Bifidus Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Bifidus Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Bifidus Sales by Country
- 10.1.1 South America Bifidus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Bifidus Sales by Country (2021-2026)
- 10.1.3 South America Bifidus Sales Forecast by Country (2027-2032)
- 10.2 South America Bifidus Market Size by Country
- 10.2.1 South America Bifidus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Bifidus Market Size by Country (2021-2026)
- 10.2.3 South America Bifidus Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Bifidus Sales by Country
- 11.1.1 Middle East and Africa Bifidus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Bifidus Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Bifidus Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Bifidus Market Size by Country
- 11.2.1 Middle East and Africa Bifidus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Bifidus Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Bifidus Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Bifidus Value Chain Analysis
- 12.1.1 Bifidus Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Bifidus Production Mode & Process
- 12.2 Bifidus Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Bifidus Distributors
- 12.2.3 Bifidus Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst